These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11902118)

  • 1. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis.
    Zimmer L; Mauger G; Le Bars D; Bonmarchand G; Luxen A; Pujol JF
    J Neurochem; 2002 Jan; 80(2):278-86. PubMed ID: 11902118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus.
    Zimmer L; Rbah L; Giacomelli F; Le Bars D; Renaud B
    J Nucl Med; 2003 Sep; 44(9):1495-501. PubMed ID: 12960198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.
    Udo de Haes JI; Cremers TI; Bosker FJ; Postema F; Tiemersma-Wegman TD; den Boer JA
    Neuropsychopharmacology; 2005 Sep; 30(9):1624-31. PubMed ID: 15827572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Displacement of the PET ligand 18F-MPPF by the electrically evoked serotonin release in the rat hippocampus.
    Rbah L; Leviel V; Zimmer L
    Synapse; 2003 Sep; 49(4):239-45. PubMed ID: 12827643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.
    Passchier J; van Waarde A; Pieterman RM; Elsinga PH; Pruim J; Hendrikse HN; Willemsen AT; Vaalburg W
    J Nucl Med; 2000 Nov; 41(11):1830-5. PubMed ID: 11079490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine.
    Hume S; Hirani E; Opacka-Juffry J; Myers R; Townsend C; Pike V; Grasby P
    Synapse; 2001 Aug; 41(2):150-9. PubMed ID: 11400181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of p-[(18)F]MPPF, a fluoro analog of WAY-100635 for visualization of 5-HT(1a) receptors.
    Ginovart N; Hassoun W; Le Bars D; Weissmann D; Leviel V
    Synapse; 2000 Mar; 35(3):192-200. PubMed ID: 10657026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats.
    Plenevaux A; Weissmann D; Aerts J; Lemaire C; Brihaye C; Degueldre C; Le Bars D; Comar D; Pujol J; Luxen A
    J Neurochem; 2000 Aug; 75(2):803-11. PubMed ID: 10899958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats.
    Passchier J; van Waarde A; Doze P; Elsinga PH; Vaalburg W
    Eur J Pharmacol; 2000 Nov; 407(3):273-80. PubMed ID: 11068023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-(2'-Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors.
    Thielen RJ; Fangon NB; Frazer A
    J Pharmacol Exp Ther; 1996 May; 277(2):661-70. PubMed ID: 8627543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.
    Laćan G; Plenevaux A; Rubins DJ; Way BM; Defraiteur C; Lemaire C; Aerts J; Luxen A; Cherry SR; Melega WP
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2256-66. PubMed ID: 18604533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of a radiosensitive intracerebral probe to monitor 18F-MPPF binding in mouse hippocampus in vivo.
    Desbrée A; Verdurand M; Godart J; Dubois A; Mastrippolito R; Pain F; Pinot L; Delzescaux T; Gurden H; Zimmer L; Lanièce P
    J Nucl Med; 2008 Jul; 49(7):1155-61. PubMed ID: 18552137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: a continuous infusion PET study in conscious monkeys.
    Udo de Haes JI; Harada N; Elsinga PH; Maguire RP; Tsukada H
    Synapse; 2006 Jan; 59(1):18-26. PubMed ID: 16237679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin.
    Maeda J; Suhara T; Ogawa M; Okauchi T; Kawabe K; Zhang MR; Semba J; Suzuki K
    Synapse; 2001 May; 40(2):122-9. PubMed ID: 11252023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization.
    Zimmer L; Riad M; Rbah L; Belkacem-Kahlouli A; Le Bars D; Renaud B; Descarries L
    Neuroimage; 2004 Jul; 22(3):1421-6. PubMed ID: 15219613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying drug-related 5-HT1A receptor occupancy with.
    Passchier J; van Waarde A; Pieterman RM; Willemsen AT; Vaalburg W
    Psychopharmacology (Berl); 2001 May; 155(2):193-7. PubMed ID: 11401009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
    la Fougère C; Böning G; Bartmann H; Wängler B; Nowak S; Just T; Wagner E; Winter P; Rominger A; Förster S; Gildehaus FJ; Rosa-Neto P; Minuzzi L; Bartenstein P; Potschka H; Cumming P
    Neuroimage; 2010 Jan; 49(2):1406-15. PubMed ID: 19796699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of 5-HT(1A) receptors in human brain using p-MPPF kinetic modelling and PET.
    Sanabria-Bohórquez SM; Biver F; Damhaut P; Wikler D; Veraart C; Goldman S
    Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):76-81. PubMed ID: 11807610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.